Vertex Pharmaceuticals Incorporated(VRTX)
$445.21▲1.04%
Market is closed - opens 7 PM, 20 May 2024
Insights
- Vertex Pharmaceuticals Incorporated is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Vertex Pharmaceuticals Incorporated stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Vertex Pharmaceuticals Incorporated stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Vertex Pharmaceuticals Incorporated stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 79.03 | Sell |
Stochastic | 98.36, 97.53 | Neutral |
Ultimate Oscillator | 74.76 | Sell |
Stochastic Relative Strength Index | 100.0, 98.78 | Neutral |
Moving Average Convergence Divergence | 9.16, 4.53 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 425.52 | Buy |
20 | 412.42 | Buy |
50 | 409.66 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 427.83 | Buy |
20 | 418.6 | Buy |
50 | 413.3 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 423.23 | Buy |
20 | 412.28 | Buy |
50 | 409.72 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 440.58 | Buy |
20 | 429.1 | Buy |
50 | 414.57 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 445.6 | Buy |
20 | 438.75 | Buy |
50 | 417.81 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 453.57 |
Resistance L2 | 447.61 |
Resistance L1 | 444.13 |
Pivot Point | 438.17 |
Support L1 | 434.69 |
Support L2 | 428.73 |
Support L3 | 425.25 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.